Latest News
Aditxt acquires Ignite Proteomics to enhance cancer therapy selection
13 March 2026 - Aditxt Inc (NASDAQ:ADTX), a social innovation platform accelerating promising health innovations, announced on Friday that it has acquired Ignite Proteomics, a commercial-stage precision oncology company, to improve therapy selection ...
Emerald Clinical Trials honoured with 2026 Asia Pacific Biopharma Excellence Award
13 March 2026 - Emerald Clinical Trials, a global clinical research organisation (CRO), announced on Thursday that it has received the Best Clinical Trials Supplier Award: Outstanding Patient Recruitment & Engagement at the 2026 Asia-Pacific Biop...
Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004
13 March 2026 - Clinical-stage biotechnology company Inimmune Corporation announced on Thursday the completion of enrolment and dosing of the first patient in its Phase 2 allergen challenge chamber trial evaluating INI-2004 in patients with allergic ...
WuXi Biologics wins at 2026 Asia-Pacific Biopharma Excellence Awards for leadership in bioprocessing, manufacturing excellence, and digital innovation
13 March 2026 - WuXi Biologics ('WuXi Bio') (HK:2269), a global Contract Research, Development and Manufacturing Organization (CRDMO), announced on Thursday that it has received six prestigious awards and two individual leadership awards at...
Precision for Medicine opens new Japan office
12 March 2026 - Precision for Medicine, a biomarker-driven clinical research and development services organisation, announced on Wednesday the opening of its new office in Japan.The new Tokyo office strengthens Precision's local partnerships, re...